Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
REPRO-MED Systems ( (KRMD) ) has shared an announcement.
On March 30, 2026, KORU Medical Systems, Inc. amended its existing $10 million credit facility with HSBC Ventures USA Inc., consisting of a $5 million revolver and a $5 million term loan. The company has not drawn on these facilities and remains under no obligation to do so, preserving financial flexibility while improving loan terms.
The amendment extends the revolver’s maturity from December 31, 2026 to March 30, 2028 and shifts the term loan maturity from December 1, 2028 to December 1, 2029. It also lengthens the interest-only period on the term loan to at least June 30, 2027, potentially to December 31, 2027 if EBITDA milestones are met, lowers the interest rate floor to 5.50% from 6.50%, and replaces the adjusted quick ratio covenant with a more flexible liquidity and EBITDA-based covenant, easing balance sheet constraints while maintaining lender protections.
The most recent analyst rating on (KRMD) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on REPRO-MED Systems stock, see the KRMD Stock Forecast page.
Spark’s Take on KRMD Stock
According to Spark, TipRanks’ AI Analyst, KRMD is a Neutral.
The score is driven mainly by improving fundamentals (strong gross margins, narrowing losses, and operating cash flow turning positive) and constructive 2026 guidance pointing to profitability and positive cash flow. These positives are tempered by weak technicals (below key moving averages with negative MACD) and valuation risk tied to ongoing net losses and no dividend support.
To see Spark’s full report on KRMD stock, click here.
More about REPRO-MED Systems
KORU Medical Systems, Inc. operates in the medical devices industry, providing infusion therapy systems used for subcutaneous drug delivery. The company focuses on supplying specialized equipment to patients with chronic conditions, positioning its products within the broader healthcare and home infusion markets.
Average Trading Volume: 187,061
Technical Sentiment Signal: Buy
Current Market Cap: $200.3M
Find detailed analytics on KRMD stock on TipRanks’ Stock Analysis page.